A carregar...
CCNE1 Amplification as a Predictive Biomarker of Chemotherapy Resistance in Epithelial Ovarian Cancer
Ovarian cancer is the most-deadly gynecologic malignancy, with greater than 14,000 women expected to succumb to the disease this year in the United States alone. In the front-line setting, patients are treated with a platinum and taxane doublet. Although 40–60% of patients achieve complete clinical...
Na minha lista:
| Publicado no: | Diagnostics (Basel) |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
MDPI
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7277958/ https://ncbi.nlm.nih.gov/pubmed/32380689 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/diagnostics10050279 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|